Tesamorelin + Ipamorelin (Blend)
What is Tesamorelin + Ipamorelin (Blend)?
Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone (GH) through the natural GHRH pathway. It has a 44–amino acid structure with modifications that increase its stability and half-life compared to natural GHRH. Ipamorelin is a selective growth hormone secretagogue (GHS) and ghrelin receptor agonist that triggers GH release via a separate pathway from GHRH. When used together in research settings, Tesamorelin and Ipamorelin may have complementary effects on GH release by acting on two different hormonal signaling mechanisms.
Mechanisms of Action
Tesamorelin + Ipamorelin may work together by:
- Tesamorelin: Binding to GHRH receptors in the pituitary to increase GH pulse amplitude and frequency
- Ipamorelin: Activating ghrelin receptors (GHS-R1a) to enhance GH secretion without significantly affecting cortisol or prolactin levels
- Potentially increasing circulating insulin-like growth factor-1 (IGF-1) to support tissue growth and repair
- Acting synergistically to promote a greater and more sustained GH release than either peptide alone
- Supporting protein synthesis, tissue recovery, and metabolic regulation in research models
Tesamorelin
Tesamorelin is a synthetic peptide that stimulates the release of growth hormone by mimicking the body's natural Growth Hormone-Releasing Hormone (GHRH). It is FDA-approved for reducing excess abdominal fat in HIV-positive patients with lipodystrophy and is also being studied for its potential effects on body composition, metabolism, and healthy aging.
View peptide
Ipamorelin
Ipamorelin is a selective growth hormone secretagogue (GHS) peptide that stimulates the body's natural production of growth hormone (GH). It works by mimicking ghrelin, the "hunger hormone," but without significantly increasing cortisol or other unwanted side effects seen with older GH peptides. It's commonly studied for its potential benefits in muscle growth, recovery, and anti-aging.
View peptide
Research Highlights
Tesamorelin
FDA-Approved for HIV-Associated Visceral Fat Reduction
Tesamorelin (Egrifta®) is FDA-approved for reducing visceral adipose tissue (VAT) in patients with HIV-associated lipodystrophy, with clinical trials demonstrating significant VAT loss and improvements in body composition, lipid profile, and insulin sensitivity.
Versatile Metabolic & Longevity Applications
Emerging research is exploring Tesamorelin’s effects beyond HIV lipodystrophy, including reducing hepatic steatosis and liver fibrosis in NAFLD, improving cognitive function, insulin resistance, and other aging-related metabolic markers.
Ongoing Research in Cognitive Aging & Nerve Repair
Current Phase II trials are evaluating Tesamorelin’s potential in improving cognitive function in aging HIV populations, and in enhancing motor and sensory recovery after peripheral nerve injuries.
Favorable Metabolic Biomarker Profiles
Tesamorelin has been shown to improve lipid metabolism—lowering triglycerides by ~15% and increasing HDL—while maintaining or even enhancing insulin sensitivity, and improving glucose homeostasis.
Ipamorelin
Selective GH Secretagogue (GHS‑R1a Agonist)
Ipamorelin binds specifically to the ghrelin receptors in the pituitary, inducing growth hormone (GH) release without significantly impacting cortisol, ACTH, or prolactin—offering a cleaner profile compared to other GHRPs.
Musculoskeletal Support & Bone Health
Animal studies indicate that Ipamorelin may counteract glucocorticoid-induced muscle catabolism and increase bone mineral content, particularly enhancing tibial growth and bone density in female rats.
Precise, Pulsatile GH Release
Ipamorelin closely mimics natural GH secretion patterns by delivering targeted pulses, which helps maintain physiological hormone balance and potentially improves metabolic responses.
Potential Anti-Aging & Recovery Applications
Due to its selectivity and minimal hormonal side effects, Ipamorelin is under investigation as a research tool for muscle recovery, anti-aging protocols, and metabolic studies.
Molecular Structure
Tesamorelin
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-NH₂
C₂₂₀H₃₆₆N₇₂O₆₇S
5135.91 g/mol
Ipamorelin
Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (Aib = 2-aminoisobutyric acid, 2-Nal = 2-naphthylalanine)
C₃₈H₄₉N₉O₅
711.86 g/mol